BioSpace News Archive

Essity, a leading global hygiene and health company, announces its Cutimed® Sorbact®, has received a 2021 Innovative Technology contract from Vizient, Inc., the largest member-driven, healthcare performance improvement company in the United States.

PPJ Enterprise (OTC PINK:PPJE), a leader in Healthcare Reimbursement Cycle Expert for Complex Medical/Surgical Services and proprietary Automated Healthcare Practice Management Software, online Health Information Digital Systems and Medical Practice Information Management, is pleased to announce new business of two doctors group and the company will start processing their billing on 4/15/2021 and just hired a nationally well known digital marketing company

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.

Grand River Aseptic Manufacturing (“GRAM”), a leading parenteral contract development and manufacturing organization (“CDMO”), congratulates Johnson & Johnson on receiving emergency use authorization from the Food and Drug Administration (“FDA”) for its single-shot COVID-19 vaccine

The Federal Trade Commission announced that it will no longer challenge the merger between Einstein Healthcare Network and Jefferson Health, posing no further barriers for the two historically linked academic medical centers to combine efforts to advance their shared healthcare mission in the region.

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager.

MBF Bioscience (“MBF”), a leading provider of bioscience image analysis tools, announced today that it has completed the acquisition of Vidrio Technologies (“Vidrio”). Terms of the transaction were not disclosed.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol, today announced that Atabak Mokari has joined the company as Chief Financial Officer.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2020.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2020 financial results and provided a corporate update.